Rchr
J-GLOBAL ID:200901082718821619   Update date: Dec. 16, 2020

Suzuki Kazuhiro

スズキ カズヒロ | Suzuki Kazuhiro
Affiliation and department:
Job title: Professor
Research field  (1): Urology
Research keywords  (2): 前立腺癌 ,  前立腺癌
Papers (85):
  • Hiroji Uemura, Hisashi Matsushima, Kazuki Kobayashi, Hiroya Mizusawa, Hiroaki Nishimatsu, Karim Fizazi, Matthew Smith, Neal Shore, Teuvo Tammela, Ken-Ichi Tabata, et al. Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial. International journal of clinical oncology. 2020
  • Yukie Endo, Aina Oka, Akihito Uehara, Sayaka Toki, Sei-Ichiro Motegi, Osamu Ishikawa, Yoshiyuki Miyazawa, Kazuhiro Suzuki. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug. The Journal of dermatology. 2020. 47. 10. e359-e360
  • Nobuaki Matsubara, Kazuhiro Suzuki, Hirotaka Kazama, Shoko Tsukube, Takeshi Seto, Hideyasu Matsuyama. Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan. Journal of geriatric oncology. 2020. 11. 7. 1067-1073
  • Kazuto Ito, Mikio Kobayashi, Motokiyo Komiyama, Seiji Naito, Kazuo Nishimura, Junji Yonese, Katsuyoshi Hashine, Shiro Saito, Gaku Arai, Mitsuru Shinohara, et al. Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial. Cancer. 2020. 126. 17. 3961-3971
  • Takeshi Miyao, Hidekazu Koike, Yoshitaka Sekine, Akira Ohtsu, Daisuke Oka, Kazuhiro Suzuki. YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression. Anticancer research. 2020. 40. 9. 5091-5095
more...
MISC (429):
more...
Patents (1):
  • 前立腺癌と良性前立腺過形成の鑑別法
Books (10):
  • 去勢抵抗性前立腺がん 薬物治療UPDATE
    先端医学社 2015
  • 癌と骨
    メデイカルレビュー社 2013
  • がん骨転移のバイオロジーとマネージメント:がん治療による骨量減少(CTIBL)
    医薬ジャーナル 2012
  • 前立腺癌診療ガイドライン2012年版 疫学
    金原出版 2012
  • 前立腺癌
    今日の診断指針第6版 2011
more...
Lectures and oral presentations  (96):
  • Effects of LH-RH agonist on hormonal and cognitive function of prostate cancer patients in relation to testicular and adrenal androgens.
    (15th International Congress on Hormonal Steroids and Hormones & Cancer symposium 2012)
  • Impact of pre-treatment prostate tissue androgen content on the prediciton of future castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy.
    (15th International Congress on Hormonal Steroids and Hormones & Cancer 2012)
  • Evaluation of adrenal androgens and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia.
    (15th International Congress on Hormonal Steroids and Hormones & Cancer 2012)
  • Androgen production in periprostatic adipose tissue in prostate cancer patients.
    (27th Annual EAU Congress 2012)
  • High-fat diet increased leptin, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer.
    (27th Annual EAU Congress 2012)
more...
Education (3):
  • - 1996 Gunma University
  • - 1996 Gunma University
  • - 1988 Gunma University
Professional career (1):
  • (BLANK) (Gunma University)
Work history (2):
  • 1997 - 1999 The Ohio State University
  • 1997 - 1999 Post-doctoral fellow, Hematology/Oncology, OHIO STATE UMV
Committee career (19):
  • 日本内分泌学会 代議員
  • 日本ステロイドホルモン学会 評議員
  • 日本泌尿器科学会 評議員
  • 日本癌治療学会 評議員
  • 日本アンドロロジー学会 評議員 監事
Show all
Awards (2):
  • 2002 - 前立腺がんワークショップ医学賞
  • 1997 - 第1回北関東医学会奨励賞
Association Membership(s) (16):
American Society of Clinical Oncoogy ,  Europen Society of Medical Oncology ,  日本内分泌学会 ,  日本ステロイドホルモン学会 ,  日本家族性腫瘍学会 ,  日本泌尿器科学会 ,  日本癌治療学会 ,  日本アンドロロジー学会 ,  日本がん検診・診断学会 ,  日本透析医学会 ,  北関東医学会 ,  American Urological Association ,  American Association for Cancer Research ,  International Society of Urology ,  American Society of Clinical Oncoogy ,  Europen Society of Medical Oncology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page